Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.00906 USD | +14.39% | +1.11% | -52.11% |
04-16 | AXIM Biotechnologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-15 | AXIM Biotechnologies, Inc. announced that it has received $0.814555 million in funding | CI |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
AXIM BIOTECHNOLOGIES, INC. | Other Biotechnology & Medical Research | +14.39% | +1.11% | -52.11% | -62.86% | -98.96% | 2.31M | - | - | - |
Technical Rankings Surperformance
- Stock Market
- Equities
- AXIM Stock
- Charts AXIM Biotechnologies, Inc.
- Comparison Chart